Oscillation and rapid changes of NF1 mRNA steady-state levels in cultured human keratinocytes

Archives of Dermatological Research

Volumn 292, Issue 8, 2000, Pages 422-424

  Pummi, K ^a   Yla Outinen H ^b   Peltonen, J ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Cell regulation; mRNA stability; Neurofibromin; Type 1 neurofibromatosis

Indexed keywords

MESSENGER RNA; NEUROFIBROMIN;

ARTICLE; CELL CULTURE; CULTURE MEDIUM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; NEUROFIBROMATOSIS; PRIORITY JOURNAL;

ADULT; AGED; CELLS, CULTURED; HOMEOSTASIS; HUMANS; KERATINOCYTES; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROFIBROMIN 1; OSCILLOMETRY; REFERENCE VALUES; RNA, MESSENGER; TIME FACTORS;

EID: 0033852186     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030000155     Document Type: Article

References (21)

1. Basu TN, Gutmann DH, Fletcher JA, Glower TW, Collins FS, Downward J (1992) Aberrant regulation of ras proteins in malignant tumour cells from type I neurofibromatosis patients. Nature 356: 713-715
2. Bollag G, McCormick F (1992) NF is enough of GAP. Nature 35: 663-664
3. Boyce ST, Ham RG (1985) Cultivation, frozen storage, and clonal growth of normal human keratinocytes in serum free media. J Tissue Culture Methods 9: 83-93
4. Chomchynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
5. DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowy D (1992) Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type I) neurofibromatosis. Cell 69: 265-273
6. Eckert RL, Crish JF, Robinson NA (1997) The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77: 397-424
7. Griesser J, Kaufmann D, Maier B, Mailhammer R, Kuehl P, Krone W (1997) Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors. J Invest Dermatol 108: 275-280
8. Gutmann DH, Wood DL, Collins FS (1991) Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci U S A 88: 9658-9662
9. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278: 51-57
10. Haeussler J, Haeusler J, Striebel AM, Assum G, Vogel W, Furneuaux H, Krone W (2000) Tumor antigen HuR binds specifically to one of five protein-binding segments in the 3′-untranslated region of the neurofibromin messenger RNA. Biochem Biophys Res Commun 267: 726-732
11. Hermonen J, Hirvonen O, Ylä-Outinen H, Lakkakorpi J, Björkstrand AS, Laurikainen L, Kallioinen M, Oikarinen A, Peltonen S, Peltonen J (1995) Neurofibromin: expression by normal human keratinocytes in vivo and in vitro, and in epidermal malignancies. Lab Invest 73: 221-228
12. Hong FD, Huang HJS, To H, Young LJS, Oro A, Bookstein R, Lee EYHP, Lee WH (1989) Structure of the human retinoblastoma gene. Proc Natl Acad Sci U S A 86: 5502-5506
13. Kaufmann D, Bartelt B, Hoffmeyer S, Muller R (1999) Posttranslational regulation of neurofibromin content in melanocytes of neurofibromatosis type 1 patients. Arch Dermatol Res 291: 312-317
14. Koivunen J, Ylä-Outinen H, Korkiamäki T, Karvonen SL, Pöyhönen M, Laato M, Karvonen J, Peltonen S, Peltonen J (2000) New function for NF1 tumor suppressor. J Invest Dermatol 114: 473-479
15. Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3: 122-126
16. Marchuk DA, Saulino AM, Tavakkol R, Swaroop M, Wallace MR, Andersen LB, Mitchell AL, Gutmann DH, Boguski M, Collins FS (1991) cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11: 931-940
17. Metheny LJ, Cappione AJ, Skuse GR (1995) Genetic and epigenetic mechanisms in the pathogenesis of neurofibromatosis type I. J Neuropathol Exp Neurol 54: 753-760
18. Paterson IC, Patel V, Sandy JR, Prime SS, Yeudall WA (1995) Effects of transforming growth factor beta-1 on growth-regulatory genes in tumour-derived human oral keratinocytes. Br J Cancer 72: 922-927
19. Riccardi V (1981) Von Recklinghausen neurofibromatosis. N Engl J Med 305: 1617-1627
20. Xu GF, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F (1990) The catalytic domain of neurofibromatosis type I gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63: 835-841
21. Ylä-Outinen H, Aaltonen V, Björkstrand AS, Hirvonen O, Lakkakorpi J, Vähä-Kreula M, Laato M, Peltonen J (1998) Up-regulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor β1 (TGFβ1) elicited increase in neurofibromin mRNA steady state levels in dermal fibroblasts. J Invest Dermatol 3: 232-237